| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M114.620252 |
| P8608 | Fatcat ID | release_o2ftc57fn5hkxjguvwgsnwj53e |
| P932 | PMC publication ID | 4358260 |
| P698 | PubMed publication ID | 25616665 |
| P5875 | ResearchGate publication ID | 271537116 |
| P2093 | author name string | Yang Zhang | |
| Jing Wang | |||
| Geoffrey Talmon | |||
| Liying Geng | |||
| P2860 | cites work | Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 |
| MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias | Q24564008 | ||
| MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) | Q24630209 | ||
| Combinatorial microRNA target predictions | Q27860510 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux | Q28186424 | ||
| 5-Fluorouracil: mechanisms of action and clinical strategies | Q28201937 | ||
| Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 | ||
| Mechanisms of cancer drug resistance | Q29615849 | ||
| microRNAs as oncogenes and tumor suppressors | Q29619907 | ||
| MicroRNA-192 suppresses liver metastasis of colon cancer | Q33594662 | ||
| Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer | Q33894754 | ||
| Molecular mechanisms of drug resistance | Q34382998 | ||
| MicroRNAs in cell proliferation, cell death, and tumorigenesis. | Q34497050 | ||
| 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction | Q34605000 | ||
| Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy | Q34752616 | ||
| Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. | Q34754672 | ||
| MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. | Q35008686 | ||
| microPrimer: the biogenesis and function of microRNA. | Q36285669 | ||
| Tamoxifen-stimulated growth of breast cancer due to p21 loss | Q36423493 | ||
| MicroRNAs and chromosomal abnormalities in cancer cells | Q36617820 | ||
| The p53 miRNA interactome and its potential role in the cancer clinic | Q38124951 | ||
| Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells | Q39032730 | ||
| Inhibition of cell proliferation and increase of chemosensitivity by simultaneous knockdown of XIAP and survivin in pancreatic carcinoma cells | Q39044339 | ||
| Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. | Q39660739 | ||
| p21(Cip1) confers resistance to imatinib in human chronic myeloid leukemia cells | Q39757253 | ||
| Chemotherapy of Gastrointestinal Cancer | Q39774854 | ||
| Induction of p53 and drug resistance following treatment with cisplatin or paclitaxel in ovarian cancer cell lines | Q40403231 | ||
| BCR/ABL recruits p53 tumor suppressor protein to induce drug resistance | Q40502504 | ||
| Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines | Q40608301 | ||
| p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells | Q40914197 | ||
| Anticancer activity of marine sponge Hyrtios sp. extract in human colorectal carcinoma RKO cells with different p53 status. | Q42180939 | ||
| Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites | Q42419115 | ||
| p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells | Q42576880 | ||
| Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients | Q43202920 | ||
| p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax. | Q44511919 | ||
| Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer | Q46133125 | ||
| A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cells | Q46908395 | ||
| Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells | Q47735652 | ||
| Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. | Q52826936 | ||
| Ceramide glycosylation potentiates cellular multidrug resistance | Q57373871 | ||
| Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose | Q68132129 | ||
| Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage | Q72910633 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| microRNA | Q310899 | ||
| colorectal carcinoma | Q25493920 | ||
| P1104 | number of pages | 11 | |
| P304 | page(s) | 6215-6225 | |
| P577 | publication date | 2015-01-23 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer | |
| P478 | volume | 290 |
| Q38807882 | CRCT1 regulated by microRNA-520 g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer |
| Q38915810 | Cancer-Related Triplets of mRNA-lncRNA-miRNA Revealed by Integrative Network in Uterine Corpus Endometrial Carcinoma. |
| Q58601661 | Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers |
| Q33720978 | Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs |
| Q42074515 | DNA damage responsive miR-33b-3p promoted lung cancer cells survival and cisplatin resistance by targeting p21WAF1/CIP1. |
| Q26766173 | Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity |
| Q64083246 | Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil |
| Q64230212 | Factors Regulating microRNA Expression and Function in Multiple Myeloma |
| Q38546133 | Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance. |
| Q38734494 | Insights into the involvement of noncoding RNAs in 5-fluorouracil drug resistance |
| Q38826542 | Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer. |
| Q38940586 | Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer |
| Q47109270 | Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer |
| Q36284814 | MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugs |
| Q47106409 | MiR-92a promotes stem cell-like properties by activating Wnt/β-catenin signaling in colorectal cancer |
| Q38800760 | MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin |
| Q37295716 | MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression |
| Q36022236 | MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer |
| Q39016759 | MicroRNAs are important regulators of drug resistance in colorectal cancer |
| Q40864983 | MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer |
| Q90429127 | MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside |
| Q38552402 | MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer. |
| Q26776039 | MicroRNAs: Clinical Relevance in Colorectal Cancer |
| Q91761884 | Molecular Insights into miRNA-Driven Resistance to 5-Fluorouracil and Oxaliplatin Chemotherapy: miR-23b Modulates the Epithelial–Mesenchymal Transition of Colorectal Cancer Cells |
| Q89881039 | Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance |
| Q43227475 | New insights into tumor dormancy: Targeting DNA repair pathways |
| Q42122998 | Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients. |
| Q26773316 | Oncogenic MicroRNAs: Key Players in Malignant Transformation |
| Q97681525 | Regulation of MYO18B mRNA by a network of C19MC miRNA-520G, IFN-γ, CEBPB, p53 and bFGF in hepatocellular carcinoma |
| Q26797350 | Regulatory Roles of Non-Coding RNAs in Colorectal Cancer |
| Q36348635 | TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells |
| Q64229129 | The Developing Story of Predictive Biomarkers in Colorectal Cancer |
| Q26765247 | The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms |
| Q58694197 | The Network of Non-coding RNAs in Cancer Drug Resistance |
| Q90419845 | The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics |
| Q42081827 | The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesis |
| Q49122621 | Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment |
| Q38762901 | Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer |
| Q90241545 | miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2) |
| Q51502591 | miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells. |
| Q92422648 | p21cip1/waf1 Coordinate Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress |
Search more.